Page last updated: 2024-08-16

pimobendan and amrinone

pimobendan has been researched along with amrinone in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19904 (36.36)18.7374
1990's4 (36.36)18.2507
2000's3 (27.27)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Erhardt, PW1
Lombardo, F; Obach, RS; Waters, NJ1
Lehot, JJ1
Meyer, W; Scholz, H1
Braunwald, E; Colucci, WS; Wright, RF1
Chiotti, D; Presbitero, P1
Furukawa, Y; Iwasaki, A; Matsumori, A; Nakamura, T; Okada, I; Ono, K; Sasayama, S; Shioi, T1
Matsumori, A; Nose, Y; Ono, K; Sasayama, S; Sato, Y; Shioi, T1
Cheng, CP; Little, WC; Ohte, N; Suzuki, M1
Matsumori, A; Nunokawa, Y; Sasayama, S1
Kimura, T; Kuwashima, H; Matsumura, C1

Reviews

3 review(s) available for pimobendan and amrinone

ArticleYear
In search of the digitalis replacement.
    Journal of medicinal chemistry, 1987, Volume: 30, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship

1987
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
    The New England journal of medicine, 1986, Feb-06, Volume: 314, Issue:6

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Administration, Oral; Aminopyridines; Amrinone; Cardiotonic Agents; Coenzymes; Enoximone; Heart; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Milrinone; Nifedipine; Oxyfedrine; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Quinazolines; Ubiquinone

1986
[New inotropic drugs].
    Cardiologia (Rome, Italy), 1988, Volume: 33, Issue:8

    Topics: Adrenergic beta-Agonists; Amrinone; Cardiotonic Agents; Deoxyepinephrine; Enoximone; Ethanolamines; Heart; Humans; Imidazoles; Milrinone; Myocardial Contraction; Propanolamines; Pyridazines; Pyridones; Vasodilator Agents; Xamoterol

1988

Other Studies

8 other study(ies) available for pimobendan and amrinone

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
[New positive inotropic drugs].
    Annales francaises d'anesthesie et de reanimation, 1991, Volume: 10, Issue:1

    Topics: Adrenergic Agonists; Amrinone; Cardiotonic Agents; Dopamine; Enoximone; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Shock, Cardiogenic

1991
Phosphodiesterase-inhibiting properties of newer inotropic agents.
    Circulation, 1986, Volume: 73, Issue:3 Pt 2

    Topics: 1-Methyl-3-isobutylxanthine; Aminopyridines; Amrinone; Animals; Calcium; Cardiotonic Agents; Cyclic AMP; Dose-Response Relationship, Drug; Guinea Pigs; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Theophylline

1986
Inotropic agents differentially inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages.
    Life sciences, 1996, Volume: 59, Issue:10

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Amrinone; Animals; Cardiotonic Agents; Cell Line; Culture Media; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide Synthase; Nitrites; Phosphodiesterase Inhibitors; Pyrazines; Pyridazines; Quinolines

1996
Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Journal of molecular and cellular cardiology, 1996, Volume: 28, Issue:12

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; 8-Bromo Cyclic Adenosine Monophosphate; Amrinone; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 5; Heart Failure; Humans; Interleukin-1; Interleukin-6; Kinetics; Leukocytes, Mononuclear; Lipopolysaccharides; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperidines; Pyrazines; Pyridazines; Quinazolines; Quinolines; Tumor Necrosis Factor-alpha

1996
The cardiac effects of pimobendan (but not amrinone) are preserved at rest and during exercise in conscious dogs with pacing-induced heart failure.
    The Journal of pharmacology and experimental therapeutics, 1997, Volume: 282, Issue:1

    Topics: Amrinone; Animals; Dogs; Heart Failure; Phosphodiesterase Inhibitors; Physical Conditioning, Animal; Pyridazines; Ventricular Function, Left

1997
Pimobendan inhibits the activation of transcription factor NF-kappaB: a mechanism which explains its inhibition of cytokine production and inducible nitric oxide synthase.
    Life sciences, 2000, Oct-06, Volume: 67, Issue:20

    Topics: Amrinone; Animals; Cardiotonic Agents; Colforsin; Cytokines; Humans; Interleukin-1; Luciferases; Macrophages; Mice; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phosphodiesterase Inhibitors; Pyrazines; Pyridazines; Quinolines; Tetradecanoylphorbol Acetate; Transfection; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2000
Inhibition and facilitation by pimobendan, a calcium sensitizer, of catecholamine secretion from bovine adrenal chromaffin cells.
    Journal of pharmacological sciences, 2003, Volume: 91, Issue:3

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acetylcholine; Adrenal Glands; Amrinone; Angiotensin II; Animals; Calcium; Catecholamines; Cattle; Cells, Cultured; Chromaffin Cells; Cyclic AMP-Dependent Protein Kinases; Cyclic Nucleotide Phosphodiesterases, Type 3; Dimethylphenylpiperazinium Iodide; Histamine; Isoquinolines; Milrinone; Potassium; Pyridazines; Sulfonamides

2003
chemdatabank.com